News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 109–144
- Matches
- 158
- Sources here
- 18
- Companies here
- 5
Active search
158 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
New Providence Acquisition III Ord Shs Class A (NPAC) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of the dividend and stock split history for New Providence Acquisition III Ord Shs Class A (NPAC), noting that no dividends have been distributed in the past five years. It also presents basic stock information such as its current …
Provident Financial Holdings Inc (PROV) SVP discloses share ownership
Provident Financial Holdings Inc. (PROV) Senior Vice President Michael Scott Van Stockum has disclosed his share ownership in a recent Form 3 filing. He holds 5,684 common shares indirectly through an Employee Stock Ownership Plan and 4,323 shares directly, which include restricted shares vesting …
Provident Financial Holdings (PROV) SVP granted 6,000 restricted shares
Provident Financial Holdings' Senior Vice President, Michael Scott Van Stockum, has reported the acquisition of 6,000 restricted shares of common stock on July 23, 2026. This grant increased his direct holdings to 10,323 shares, with vesting schedules extending to 2030. The transaction, filed as …
OVID|Ovid Therapeutics Inc|Price:2.355|Chg%:+0.025
TradingKey provides a comprehensive analysis of Ovid Therapeutics Inc (OVID), highlighting its strong fundamentals, high growth potential, and "Strong Buy" rating from multiple analysts, with a target price of $5.50. Despite a recent weak stock market performance, the company's revenue has grown significantly, and …
Provident Financial Services, Inc Revenue Breakdown – BOATS:PFS
Provident Financial Services, Inc. (PFS) generated $869.58 million USD in revenue last year, with its Banking and Related Activities segment being the top performer, contributing $870.40 million USD. The majority of this revenue, $870.40 million USD, originated from the United States, showing an increase …
Provident Financial Holdings Inc (PROV) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Provident Financial Holdings Inc (PROV), outlining its major shareholders and institutional holdings. Key shareholders include Provident Savings Bank, F.S.B. ESOP, Dimensional Fund Advisors, L.P., and Raffles Capital Management, LLC, alongside a breakdown by shareholder type. The report …
Ovid Therapeutics Inc. Revenue Breakdown – GETTEX:1OT
Ovid Therapeutics Inc. (GETTEX:1OT) generated 6.17 million EUR in revenue last year, primarily from its "Medicines for Brain Conditions with Significant Unmet Need" segment. This revenue marks a significant increase from the previous year's 546.74 thousand EUR, with the United States being the primary …
Ovid Therapeutics Inc (OVID) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Ovid Therapeutics Inc (OVID), outlining its major shareholders by proportion, including RA Capital Management, Takeda Pharmaceutical, and Affinity Asset Advisors. It also categorizes shareholder types such as hedge funds, investment advisors, and corporations, and provides a breakdown …
PFS|Provident Financial Services Inc|Price:23.890|Chg%:+0.135
This article provides a detailed financial overview and analyst ratings for Provident Financial Services Inc (PFS), highlighting its healthy fundamentals and high growth potential. The stock is currently trading at $23.890, considered fairly valued, with a strong institutional ownership and a consensus 'Buy' rating …
Provident Financial (NASDAQ: PROV) sets $0.14 quarterly dividend with Sept. 3 payout
Provident Financial Holdings, Inc. (NASDAQ: PROV) has announced a quarterly cash dividend of $0.14 per share, payable on September 3, 2026. Shareholders of record by August 13, 2026, will be eligible to receive this dividend. The announcement was made via an 8-K filing, with …
Ovid Therapeutics Inc Today's Market Trends | OVID Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey
Ovid Therapeutics Inc. (OVID) shows healthy fundamentals and significant growth potential, though its stock price is expected to trend down in the medium term despite strong buy ratings from analysts. The company is focused on developing small-molecule medicines for brain conditions, with a pipeline …
Provident Financial (NASDAQ: PROV) names CEO to board and new lending chief
Provident Financial Holdings, Inc. announced governance changes, appointing President and CEO Donavon P. Ternes to the Boards of Directors of both the Corporation and Provident Savings Bank, F.S.B. This appointment fills vacancies left by a director's passing. Additionally, Michael S. Van Stockum was named …
Provident Financial Holdings Announces Quarterly Cash Dividend
Provident Financial Holdings, Inc. announced that its Board of Directors has declared a quarterly cash dividend of $0.14 per share. Shareholders of record by August 13, 2026, will receive the dividend, payable on September 3, 2026. The announcement includes a safe-harbor statement regarding forward-looking …
Technical Reactions to PROV Trends in Macro Strategies
This article analyzes Provident Financial Holdings Inc. (NASDAQ: PROV) using AI models, highlighting a neutral near and mid-term outlook with a potential long-term positive bias. It presents specific trading strategies (position, momentum breakout, risk hedging) with entry points, targets, and stop losses. The analysis …
Provident Sets Sept. 3 Payment for $0.14 Quarterly Cash Dividend
Provident Financial Holdings (NASDAQ: PROV) announced a quarterly cash dividend of $0.14 per share on its common stock. Shareholders of record by August 13, 2026, will
Provident Strengthens its Commitment to Local Communities with $50,000 in Grants to 6 Non-Profit Organizations
Provident Bank has awarded $50,000 in grants to six non-profit organizations through the Federal Home Loan Bank of New York (FHLBNY) Small Business Recovery Grant Program. These grants aim to support local non-profits facing economic challenges, helping them expand their impact and continue providing …
Provident Financial Holdings, Inc. To Host Earnings Release Conference Call
Provident Financial Holdings, Inc. (PROV) announced it will release its fourth quarter and fiscal year 2026 earnings before market open on Tuesday, July 28, 2026. The company will also host a conference call for investors and analysts on Wednesday, July 29, 2026, at 9:00 …
Provident Financial Holdings to announce Q4 and FY26 results
Provident Financial Holdings, Inc. will release its financial results for the fourth quarter and fiscal year 2026 before the market opens on July 28, 2026. The company will also host a conference call on July 29, 2026, at 9:00 a.m. Pacific time to discuss …
Provident Financial Holdings updates financial calendar with earnings release, investor call
Provident Financial Holdings has announced its financial calendar, scheduling the release of its fourth-quarter and fiscal 2026 earnings for July 28, 2026, before the market open. An investor and analyst conference call is set for July 29, 2026, at 9:00 a.m. Pacific to discuss …
Provident Financial results arrive before market open July 28
Provident Financial Holdings (PROV) will release its fourth quarter and fiscal year 2026 earnings before the market opens on Tuesday, July 28, 2026. The company will also host a conference call for institutional investors and bank analysts on Wednesday, July 29, 2026, at 9:00 …
Sharemaestro market context Trend signal active 52 weeks +29.1%B.Riley reiterates Buy on Ovid Therapeutics stock, $5 target
B.Riley has reiterated a Buy rating and a $5.00 price target for Ovid Therapeutics Inc (NASDAQ:OVID), citing a compelling risk-reward profile and significant pipeline potential. The firm highlights expected readouts for OV329 and KCC2 between late 2026 and early 2027, with OV329 alone potentially …
Understanding the Setup: (PFS) and Scalable Risk
This article provides an in-depth analysis of Provident Financial Services Inc (NYSE: PFS), highlighting a strong near-term sentiment leading to a long-term positive bias. It details an exceptional 20.6:1 risk-reward setup targeting a 6.2% gain against a 0.3% risk, along with three distinct AI-generated …
PFS stock trades steadily as Provident Financial Services integrates Lakeland Bancorp merger synergi
Provident Financial Services (PFS) stock is trading steadily as the company focuses on integrating its merger with Lakeland Bancorp. The bank reported increased net income and net interest income in Q1 2024, despite a challenging interest rate environment, and is making progress on realizing …
Provident Financial Services (PFS) Could Be 4% Undervalued As Digital Banking Progress Draws Focus
Provident Financial Services (PFS) is currently trading at $24.07, appearing undervalued by approximately 4% compared to a narrative-driven fair value of $25.00. The company's investments in digital banking and data analytics are expected to improve efficiency and boost net margins and fee income as …
Provident Financial Services stock hits 52-week high at 24.24 USD
Provident Financial Services Inc. (PFS) stock reached a 52-week high of $24.24. The company has a P/E ratio of 10.29 and offers a 4.06% dividend yield, having consistently paid dividends for 24 years. Despite InvestingPro suggesting the stock is slightly overvalued, it recently reported …
Anthony Petrazzuoli Joins Provident Bank as Senior Vice President, Deposit & Payments Operations Director
Anthony Petrazzuoli has been appointed as Senior Vice President, Deposit & Payments Operations Director at Provident Bank, bringing over 25 years of experience in banking operations and leadership. In his new role, he will oversee deposit account operations, payment processing, ATM operations, and debit …